Skip to Content

711 (Mesalamine Delayed-Release 1.2 g)

Pill with imprint 711 is Brown, Elliptical / Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for 711

Mesalamine Delayed-Release

Imprint
711
Strength
1.2 g
Color
Brown
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
National Drug Code (NDC)
68382-0711
Inactive Ingredients
carboxymethylcellulose sodium, microcrystalline cellulose, ferric oxide red, ferric oxide yellow, hypromelloses, magnesium stearate, methacrylic acid, silicon dioxide, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "711"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.